Bessemer Securities LLC decreased its position in The Cooper Companies, Inc. (NYSE:COO – Free Report) by 21.8% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 4,655 shares of the medical device company’s stock after selling 1,300 shares during the period. Cooper Companies makes up 1.2% of Bessemer Securities LLC’s portfolio, making the stock its 15th largest position. Bessemer Securities LLC’s holdings in Cooper Companies were worth $1,785,000 at the end of the most recent quarter.
A number of other large investors have also made changes to their positions in the company. Venturi Wealth Management LLC raised its position in shares of Cooper Companies by 59.3% during the second quarter. Venturi Wealth Management LLC now owns 86 shares of the medical device company’s stock worth $33,000 after purchasing an additional 32 shares during the period. KB Financial Partners LLC acquired a new stake in Cooper Companies during the 1st quarter worth approximately $34,000. Clear Street Markets LLC lifted its stake in Cooper Companies by 93.9% in the first quarter. Clear Street Markets LLC now owns 95 shares of the medical device company’s stock valued at $35,000 after buying an additional 46 shares in the last quarter. Colonial Trust Co SC acquired a new position in shares of Cooper Companies in the first quarter valued at approximately $41,000. Finally, Trivant Custom Portfolio Group LLC bought a new stake in shares of Cooper Companies during the first quarter worth $58,000. Institutional investors own 96.31% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts recently commented on COO shares. Morgan Stanley initiated coverage on shares of Cooper Companies in a research report on Thursday, September 28th. They issued an “equal weight” rating and a $410.00 price objective on the stock. Mizuho reaffirmed a “buy” rating and set a $440.00 price objective on shares of Cooper Companies in a research report on Monday, August 28th. Citigroup dropped their target price on Cooper Companies from $440.00 to $420.00 in a research report on Monday, October 2nd. StockNews.com started coverage on Cooper Companies in a research note on Thursday, October 5th. They issued a “hold” rating on the stock. Finally, Robert W. Baird raised their price target on shares of Cooper Companies from $400.00 to $410.00 and gave the stock an “outperform” rating in a research note on Thursday, August 31st. Three research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $401.30.
Cooper Companies Stock Down 0.1 %
Shares of NYSE:COO traded down $0.47 during midday trading on Monday, hitting $336.65. The stock had a trading volume of 11,534 shares, compared to its average volume of 289,628. The company has a market cap of $16.67 billion, a P/E ratio of 60.96, a PEG ratio of 2.69 and a beta of 0.94. The Cooper Companies, Inc. has a 12 month low of $302.88 and a 12 month high of $399.62. The business’s 50-day simple moving average is $325.99 and its 200-day simple moving average is $358.79. The company has a quick ratio of 0.99, a current ratio of 1.72 and a debt-to-equity ratio of 0.33.
Cooper Companies (NYSE:COO – Get Free Report) last announced its quarterly earnings data on Wednesday, August 30th. The medical device company reported $3.35 EPS for the quarter, beating analysts’ consensus estimates of $3.34 by $0.01. The company had revenue of $930.20 million during the quarter, compared to the consensus estimate of $899.77 million. Cooper Companies had a net margin of 7.83% and a return on equity of 8.17%. The company’s quarterly revenue was up 10.3% on a year-over-year basis. During the same quarter last year, the firm posted $3.19 EPS. On average, sell-side analysts forecast that The Cooper Companies, Inc. will post 12.81 earnings per share for the current fiscal year.
Cooper Companies Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific.
- Five stocks we like better than Cooper Companies
- Dividend Tax Calculator
- An inside day for Target says another sell-off looms
- Find and Profitably Trade Stocks at 52-Week Lows
- 2 stocks that under-promised and over-delivered on their earnings
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- 2 overlooked stocks that crushed earnings but traded lower
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.